Literature DB >> 19946044

Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction.

Talia Eldar-Geva1, Harry J Hirsch, Fortu Benarroch, Orit Rubinstein, Varda Gross-Tsur.   

Abstract

OBJECTIVE: The variable hypogonadism in Prader-Willi syndrome (PWS) has generally been attributed to hypothalamic dysfunction. Recent studies have documented primary testicular dysfunction in PWS males. Our aims were to characterize sexual development and reproductive hormones in PWS females and to investigate the etiology of hypogonadism.
DESIGN: A cross-sectional study.
METHODS: Physical examination was performed on 45 PWS females (aged 6 weeks to 32 years) and blood samples were obtained for hormonal analyses.
RESULTS: Age of onset and progression of puberty varied; most adults had incomplete sexual development. Spontaneous menarche was reported in four (aged 15-30 years) but all had subsequently developed secondary amenorrhea or oligomennorrhea. Anti-Mullerian hormone levels were within the normal range in all age groups. Inhibin B was consistently low or undetectable; only five women had levels in the low-normal range (20-54 pg/ml). LH was normal in most children, but low (<1.0 IU/l) in 9 of 15 adults. FSH was within the normal range for age in most children, but low (<0.5 IU/l) in 10 and high in four adults. Estradiol levels were normal-low and androgen levels were normal in the majority.
CONCLUSIONS: Pubertal development in PWS females, as in males, is characterized by normal adrenarche, pubertal arrest, and hypogonadism due to variable combinations of a unique primary gonadal defect and hypothalamic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19946044     DOI: 10.1530/EJE-09-0901

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  24 in total

1.  Loss of microRNA-7a2 induces hypogonadotropic hypogonadism and infertility.

Authors:  Kashan Ahmed; Mary P LaPierre; Emanuel Gasser; Rémy Denzler; Yinjie Yang; Thomas Rülicke; Jukka Kero; Mathieu Latreille; Markus Stoffel
Journal:  J Clin Invest       Date:  2017-02-20       Impact factor: 14.808

Review 2.  Review of Prader-Willi syndrome: the endocrine approach.

Authors:  Ryan Heksch; Manmohan Kamboj; Kathryn Anglin; Kathryn Obrynba
Journal:  Transl Pediatr       Date:  2017-10

3.  Approach to the child with prader-willi syndrome.

Authors:  Jennifer L Miller
Journal:  J Clin Endocrinol Metab       Date:  2012-11       Impact factor: 5.958

4.  Early Detection and Management of Prader-Willi Syndrome in Egyptian Patients.

Authors:  Hala T El-Bassyouni; Nagwa Hassan; Inas Mahfouz; Azza E Abd-Elnaby; Mostafa I Mostafa; Angie M S Tosson
Journal:  J Pediatr Genet       Date:  2019-08-04

Review 5.  Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.

Authors:  Rasmus Sode-Carlsen; Stense Farholt; Kai Fr Rabben; Jens Bollerslev; Thomas Schreiner; Anne Grethe Jurik; Jens Sandahl Christiansen; Charlotte Höybye
Journal:  Endocrine       Date:  2011-11-12       Impact factor: 3.633

Review 6.  Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes.

Authors:  Louisa Kalsner; Stormy J Chamberlain
Journal:  Pediatr Clin North Am       Date:  2015-04-22       Impact factor: 3.278

7.  Mutational analysis of the necdin gene in patients with congenital isolated hypogonadotropic hypogonadism.

Authors:  Daiane Beneduzzi; Anita K Iyer; Ericka Barbosa Trarbach; Acacio P Silveira-Neto; Letícia G Silveira; Cintia Tusset; Kathleen Yip; Berenice B Mendonça; Pamela L Mellon; Ana Claudia Latronico
Journal:  Eur J Endocrinol       Date:  2011-05-04       Impact factor: 6.664

Review 8.  Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.

Authors:  Giovanna Muscogiuri; Gloria Formoso; Gabriella Pugliese; Rosaria Maddalena Ruggeri; Elisabetta Scarano; Annamaria Colao
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

9.  Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome.

Authors:  T N Hangartner; D F Short; T Eldar-Geva; H J Hirsch; M Tiomkin; A Zimran; V Gross-Tsur
Journal:  Osteoporos Int       Date:  2016-07-04       Impact factor: 4.507

10.  Prader-Willi Syndrome with Angelman Syndrome in the Offspring.

Authors:  Donatella Greco; Luigi Vetri; Letizia Ragusa; Mirella Vinci; Angelo Gloria; Paola Occhipinti; Angela Antonia Costanzo; Giuseppe Quatrosi; Michele Roccella; Serafino Buono; Corrado Romano
Journal:  Medicina (Kaunas)       Date:  2021-05-08       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.